Dose-adjusting epirubicin in patients with altered liver function - when classical pharmacology makes good practical sense

By Gianni L.  

European Journal of Cancer, Vol. 39, Iss. 5, 2003-03 ,pp. : 557-559

Elsevier

Access to resources Recommend Favorite

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

By Fountzilas George   Pectasides Dimitrios   Christodoulou Christos   Timotheadou Eleni   Economopoulos Theofanis   Papakostas Pavlos   Papadimitriou Christos   Gogas Helen   Efstratiou Ioannis   Skarlos Dimosthenis  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 479-488

Humana Press, Inc

Access to resources Recommend Favorite

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

By Palumbo R.   Neumaier C.   Cosso M.   Bertero G.   Raffo P.   Spadini N.   Valente S.   Villani G.   Pastorino M.   Toma S.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 66-72

Elsevier

Access to resources Recommend Favorite

Randomised Study of High-dose Epirubicin Versus High-dose Epirubicin-Cisplatin Chemotherapy for Advanced Soft Tissue Sarcoma

By Jelic S.   Kovcin V.   Milanovic N.   Babovic N.   Kreacic M.   Ristovic Z.   Vlajic M.   Filipovic-Ljeskovic I.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite